UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

1,4-Dihydropyridines (DHPs) - a class of very potent drugs: syntheses of isotopically labeled DHP derivatives during the last four decades

Journal of labelled compounds & radiopharmaceuticals, 2007-08, Vol.50 (9-10), p.818-830

Pleiss, U.

2007

Volltextzugriff (PDF)

Labelling of the guanylate cyclase activator cinaciguat (BAY 58-2667) with carbon-14, tritium and stable isotopes

Journal of labelled compounds & radiopharmaceuticals, 2010-03, Vol.53 (3), p.130-139

2010

Volltextzugriff (PDF)

Pharmacokinetics of BAY 59-7939 - an oral, direct Factor Xa inhibitor - in rats and dogs

Xenobiotica, 2005-09, Vol.35 (9), p.891-910

2005

Volltextzugriff (PDF)

Synthesis of [3H] vardenafil, Levitra®, using a new labeling technique

Journal of labelled compounds & radiopharmaceuticals, 2003-11, Vol.46 (13), p.1241-1247

Pleiss, U.

2003

Volltextzugriff (PDF)

Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors

RNA (Cambridge), 1999-07, Vol.5 (7), p.939-946, Article S1355838299990210

1999

Volltextzugriff (PDF)

Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids

Science (American Association for the Advancement of Science), 2003-02, Vol.299 (5608), p.893-896

2003

Volltextzugriff (PDF)

Syntheses of [2H3, 15N], [14C]Nexavar™ and its labeled metabolites

Journal of labelled compounds & radiopharmaceuticals, 2006-06, Vol.49 (7), p.603-613

2006

Volltextzugriff (PDF)

Syntheses of [14C]BAY 59-7939 and its radiolabeled metabolite M-4

Journal of labelled compounds & radiopharmaceuticals, 2006-10, Vol.49 (11), p.929-934

2006

Volltextzugriff (PDF)

NO-independent regulatory site on soluble guanylate cyclase

Nature (London), 2001-03, Vol.410 (6825), p.212-215

2001

Volltextzugriff (PDF)

NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

British journal of pharmacology, 2002-07, Vol.136 (5), p.773-783

2002

Volltextzugriff (PDF)

Synthesis of a 11C-labelled taxane derivative by [1-11C]acetylation

Journal of labelled compounds & radiopharmaceuticals, 2006-03, Vol.49 (4), p.357-365

2006

Volltextzugriff (PDF)

Synthesis of a radiolabeled enniatin cyclodepsipeptide [3H-methyl]JES 1798

Journal of labelled compounds & radiopharmaceuticals, 1996-07, Vol.38 (7), p.651-659

1996

Volltextzugriff (PDF)

High Affinity Binding of a Potassium Channel Agonist to Intact Rat Insulinoma Cells

Biochemical and biophysical research communications, 1993-01, Vol.190 (2), p.551-558

1993

Volltextzugriff (PDF)

Synthesis of a radiolabeled cyclodepsipeptide [3H-methyl]PF1022A

Journal of labelled compounds & radiopharmaceuticals, 1996-01, Vol.38 (1), p.61-69

1996

Volltextzugriff (PDF)

Synthesis of a 11 C‐labelled taxane derivative by [1‐ 11 C]acetylation

Journal of labelled compounds & radiopharmaceuticals, 2006-03, Vol.49 (4), p.357-365

2006

Volltextzugriff (PDF)

Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X 1005: implications for biological regulation of 5-lipoxygenase

Agents and Actions, 1994-11, Vol.43 (1-2), p.64-68

1994

Volltextzugriff (PDF)

Syntheses of [4-14c] and [6-14c]nisoldipine

Journal of labelled compounds & radiopharmaceuticals, 1988-12, Vol.25 (12), p.1393-1400

1988

Volltextzugriff (PDF)

ChemInform Abstract: 1,4-Dihydropyridines (DHPs): A Class of Very Potent Drugs - Syntheses of Isotopically Labeled DHP Derivatives During the Last Four Decades

ChemInform, 2008-10, Vol.39 (42), p.no-no

Pleiss, U.

2008

Volltextzugriff (PDF)

Synthesis of (+)-N-(6-Ethoxy[2,4-3H]phenyl)-N-(1,2,2-trimethylpropyl)-2-nitroethene-1,1-diamine ([3H]BAY x 9228)

Journal of labelled compounds & radiopharmaceuticals, 1993-08, Vol.33 (8), p.681-686

1993

Volltextzugriff (PDF)

Partial synthesis of [6α-3H]gibberellin-A3 of high specific activity

Journal of labelled compounds & radiopharmaceuticals, 1983-12, Vol.20 (12), p.1413-1414

1983

Volltextzugriff (PDF)

NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272

BMC pharmacology, 2001-12, Vol.1 (1), p.13-13

2001

Volltextzugriff (PDF)

Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X1005. Implications for biological regulation of 5-lipoxygenase

Advances in prostaglandin, thromboxane, and leukotriene research, 1994, Vol.22, p.23

1994

Volltextzugriff (PDF)

Ein Verfahren zur Herstellung von Mehrfach mit Tritium Markiertem Thymin BZW. Thymidin

Journal of labelled compounds & radiopharmaceuticals, 1983-12, Vol.20 (12), p.1355-1362

1983

Volltextzugriff (PDF)

Tritium labeling of gonadotropin releasing hormone in its proline and histidine residues

Peptides (New York, N.Y. : 1980), 1981-01, Vol.2 (4), p.445-452

1981

Volltextzugriff (PDF)

Partial synthesis of tritium-labelled gibberellin-A3

Journal of labelled compounds & radiopharmaceuticals, 1982-06, Vol.19 (6), p.725-733

1982

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(35)
Pharmacology & Pharmacy
(27)
Biochemistry & Molecular Biology
(25)
Chemistry
(25)
Physical Sciences
(23)
Chemistry, Medicinal
(22)
Biological And Medical Sciences
(19)
Biochemical Research Methods
(17)
Chemistry, Analytical
(17)
Medical Sciences
(16)
Pharmacology. Drug Treatments
(15)
Animals
(10)
Humans
(9)
Organic Chemistry
(9)
Rats
(8)
Exact Sciences And Technology
(7)
Binding Sites
(6)
Contrast Media. Radiopharmaceuticals
(6)
Male
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1,4-Dihydropyridines (DHPs) - a class of very potent drugs: syntheses of isotopically labeled DHP derivatives during the last four decades

Labelling of the guanylate cyclase activator cinaciguat (BAY 58-2667) with carbon-14, tritium and stable isotopes

Pharmacokinetics of BAY 59-7939 - an oral, direct Factor Xa inhibitor - in rats and dogs

Synthesis of [3H] vardenafil, Levitra®, using a new labeling technique

Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors

Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids

Syntheses of [2H3, 15N], [14C]Nexavar™ and its labeled metabolites

Syntheses of [14C]BAY 59-7939 and its radiolabeled metabolite M-4

NO-independent regulatory site on soluble guanylate cyclase

NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

Synthesis of a 11C-labelled taxane derivative by [1-11C]acetylation

Synthesis of a radiolabeled enniatin cyclodepsipeptide [3H-methyl]JES 1798

High Affinity Binding of a Potassium Channel Agonist to Intact Rat Insulinoma Cells

Synthesis of a radiolabeled cyclodepsipeptide [3H-methyl]PF1022A

Synthesis of a 11 C‐labelled taxane derivative by [1‐ 11 C]acetylation

Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X 1005: implications for biological regulation of 5-lipoxygenase

Syntheses of [4-14c] and [6-14c]nisoldipine

ChemInform Abstract: 1,4-Dihydropyridines (DHPs): A Class of Very Potent Drugs - Syntheses of Isotopically Labeled DHP Derivatives During the Last Four Decades

Synthesis of (+)-N-(6-Ethoxy[2,4-3H]phenyl)-N-(1,2,2-trimethylpropyl)-2-nitroethene-1,1-diamine ([3H]BAY x 9228)

Partial synthesis of [6α-3H]gibberellin-A3 of high specific activity

NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272

Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X1005. Implications for biological regulation of 5-lipoxygenase

Ein Verfahren zur Herstellung von Mehrfach mit Tritium Markiertem Thymin BZW. Thymidin

Tritium labeling of gonadotropin releasing hormone in its proline and histidine residues

Partial synthesis of tritium-labelled gibberellin-A3

Suchergebnisse filtern